Displaying items 121-121 of 121 in total
A regulatory filing shows hedge fund Balyasny's active trading in Avadel Pharma, exposing a merger arbitrage strategy amid a fierce bidding war.
Get your daily brief delivered to your inbox every morning at 7am
